Table 4.
Linear regression of transverse and longitudinal parameters, and RVEF in PH patients.
level | R2 | |
---|---|---|
Transverse movements | ||
fractional-SFD | apex-1 | 0.30* |
2 | 0.39* | |
3 | 0.55* | |
mid-4 | 0.70* | |
5 | 0.66* | |
6 | 0.51* | |
base-7 | 0.32* | |
SFD | apex-1 | 0.30* |
2 | 0.35* | |
3 | 0.48* | |
mid-4 | 0.62* | |
5 | 0.55* | |
6 | 0.37* | |
base-7 | 0.17* | |
Longitudinal movements | ||
fractional-TAAD | - | 0.27* |
TAPSE | - | 0.21* |
RV area change | ||
AC | - | 0.25* |
fractional-AC | - | 0.76* |
Data are determined in PH patients only. Values are mean. RV area change (AC) and fractional AC are determined in 4-chamber view.
* Significantly lower compared to control subjects (P < 0.001).